Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Cincinnati, Ohio 45220


Purpose:

The purpose of this study is to determine the efficacy of naltrexone in the treatment of cocaine dependence as measured by: 1) decreased urine benzoylecgonine (BE) levels, 2) decreased cocaine use by self-report, 3) decreased cocaine craving, and 4) retention in treatment.


Study summary:

Double-blind, placebo controlled study of the safety and efficacy of naltrexone in treating cocaine dependence in a patient sample that initiated the study while in an inpatient setting and were then followed-up for 3 months as outpatients.


Criteria:

Inclusion Criteria: 1. Meet DSM-III-R criteria for cocaine dependency, 2. 18 to 65 years of age, 3. capable of understanding the study, 4. voluntarily signed consent, 5. male or non-pregnant female using approved form of birth control. Exclusion Criteria: 1. abnormal liver function tests (SGOT, SGPT, or GGT greater than twice the normal values), 2. opioid use within the last 7 days, 3. use of neuroleptics, 4. having a severe acute medical problem, 5. unable to complete psychiatric rating scales, or 6. judged by the investigator to be unlikely to comply with the study protocol


NCT ID:

NCT00015080


Primary Contact:

Principal Investigator
Eugene Somoza, M.D., Ph.D.
Cincinnati MDRU


Backup Contact:

N/A


Location Contact:

Cincinnati, Ohio 45220
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.